July 18, 2000Lanoxin Tablets Recalled by
IL (SafetyAlerts) - The Food and
Drug Administration (FDA) today reported that Allscripts, Inc. is conducting a recall of
Lanoxin tablets because the tablets do not meet thickness specification and therefore may
Lanoxin Tablets, 0.125 mg, in bottles of 30 and 100, Rx oral cardiotonic indicated for the
treatment of mild to moderate heart failure and for the control of ventricular response
rate in patients with chronic atrial fibrillation.
Recall #D-418-0. Class III
Lot Numbers: 9355140, 0006075, and 9354174.
Glaxo Wellcome, Inc., Zebulon, North Carolina.
Allscripts, Inc., Libertyville, Illinois, by letters dated April 17, 2000, and June 7,
2000. Firm-initiated recall ongoing. This is the first public notice issued by the
California, Illinois, Iowa, Wisconsin, Pennsylvania, Arizona, Indiana, Louisiana, Florida,
Idaho, Michigan, Hawaii, Maine.
86 bottles of 30 and 19 bottles of 100 tablets were distributed; firm estimated that 30
percent of the product remained on market at time of recall initiation.
Questions concerning this recall may be directed
to the FDA at 1-888-INFO-FDA.
Notice of this product warning was sent via email
to SafeMail subscribers July 18,
Safety Alerts compiles
comprehensive safety recall information for the United States. SafeMail is a free email
service to warn consumers of faulty products and contaminated foods. For complete
information regarding current recalls, past recalls and timely product warning
notification visit: www.safetyalerts.com.